3- MAJOR MATERIAL EVENTS in early 2023 BEFORE THE EVENTS in March/April 2023!
THE STOCK HAS UNDENIABLY presented several key Fundamentals so far in 2023 that, until now, had not materialized in an escalated rise in pps.
LETS TAKE A CLOSER LOOK AT WHAT THIS COMPANY HAS BEEN DOING- BEFORE the announcement of NEW DIRECTORS, NEW LICENSES and Sales/Marketing agreements - with expanded offerings in both HUMAN and ANIMAL product lines;
HUMANS-
$BDPT current product line for humans includes PluriPain®, PrimiLungs™, SleepEZ™, MindnMemory™ and Cell Rejuven™. Cell Rejuven™ the most recently launched product is an anti-aging cell rejuvenation formulation. They also market the Lung Cleanser™ and PrimiLungs™ product in a Lung Armor™ packaging, emphasizing the anti-viral properties of the nutraceutical and general respiratory health benefits from use of the non-invasive FDA-cleared device. MindNMemory™ is a nootropic formulation designed to enhance mental clarity and memory; SleepEZ™ is a natural soporific that aids relaxation and sleep quality. They acquired the SleepEZ™ license in 2021 as PrimiSleep™, and the revised formulation for MindnMemory™ during 2022, and have commenced marketing activities for these products. Decision was also made with Lung Cleanser™ to concentrate in marketing device through wholesale channels instead.
ANIMALS-
$BDPT animal products include an Equine All-in-One™ formulation, which they market to trainers, horse owners and boarding stables, and a Canine All-in-One™ that we market directly to consumers. Anecdotal and testimonial reports are that the equine products provide significant relief from exercise induced pulmonary hemorrhaging, as well as improved coat and mane appearance and hoof health. The canine products have demonstrated significant rejuvenating benefits for older dogs, improving overall appearance and energy levels.
